Cargando…
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting
BACKGROUND: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe survival rates, treatment response rates and adverse events in patients with HIV associated NHL treated with CHOP and dose adjusted-EPOCH r...
Autores principales: | Okello, Clement D., Omoding, Abrahams, Ddungu, Henry, Mulumba, Yusuf, Orem, Jackson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446121/ https://www.ncbi.nlm.nih.gov/pubmed/32831073 http://dx.doi.org/10.1186/s12885-020-07305-2 |
Ejemplares similares
-
Survival of patients with cancer associated thrombosis at the Uganda Cancer Institute
por: Okello, Clement D, et al.
Publicado: (2021) -
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute
por: Okello, Clement D, et al.
Publicado: (2021) -
Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute
por: Menon, Manoj, et al.
Publicado: (2018) -
One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute
por: Natukunda, Barbra, et al.
Publicado: (2023) -
Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)